Follitropin is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids.
Market Analysis and Insights: Global Follitropin Market
The global Follitropin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Follitropin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Follitropin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Follitropin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Follitropin market.
Follitropin Breakdown Data by Type
Urine-Derived Follicle Stimulating Hormone
Follitropin-α
Follitropin-β
Follitropin Breakdown Data by Application
Infertility Treatment
Assisted Reproductive Technology
Based on regional and country-level analysis, the Follitropin market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Follitropin market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Gedeon Richter
Organon
Ferring
Emd Serono (Merck)
Johnson & Johnson
Solvay
Controlled Therapeutics
Vetter Pharma-Fertigung GmbH&Co. KG
MSD
IBSA
Livzon
Techwell
GenSci
Teva
Market Analysis and Insights: Global Follitropin Market
The global Follitropin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Follitropin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Follitropin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Follitropin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Follitropin market.
Follitropin Breakdown Data by Type
Urine-Derived Follicle Stimulating Hormone
Follitropin-α
Follitropin-β
Follitropin Breakdown Data by Application
Infertility Treatment
Assisted Reproductive Technology
Based on regional and country-level analysis, the Follitropin market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Follitropin market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Gedeon Richter
Organon
Ferring
Emd Serono (Merck)
Johnson & Johnson
Solvay
Controlled Therapeutics
Vetter Pharma-Fertigung GmbH&Co. KG
MSD
IBSA
Livzon
Techwell
GenSci
Teva
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Follitropin Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Urine-Derived Follicle Stimulating Hormone
1.2.3 Follitropin-α
1.2.4 Follitropin-β
1.3 Market by Application
1.3.1 Global Follitropin Market Share by Application: 2020 VS 2026
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Follitropin Market Perspective (2015-2026)
2.2 Global Follitropin Growth Trends by Regions
2.2.1 Follitropin Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Follitropin Historic Market Share by Regions (2015-2020)
2.2.3 Follitropin Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Follitropin Players by Market Size
3.1.1 Global Top Follitropin Players by Revenue (2015-2020)
3.1.2 Global Follitropin Revenue Market Share by Players (2015-2020)
3.2 Global Follitropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Follitropin Revenue
3.4 Global Follitropin Market Concentration Ratio
3.4.1 Global Follitropin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Follitropin Revenue in 2019
3.5 Key Players Follitropin Area Served
3.6 Key Players Follitropin Product Solution and Service
3.7 Date of Enter into Follitropin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Follitropin Breakdown Data by Type (2015-2026)
4.1 Global Follitropin Historic Market Size by Type (2015-2020)
4.2 Global Follitropin Forecasted Market Size by Type (2021-2026)
5 Follitropin Breakdown Data by Application (2015-2026)
5.1 Global Follitropin Historic Market Size by Application (2015-2020)
5.2 Global Follitropin Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Follitropin Market Size (2015-2026)
6.2 North America Follitropin Market Size by Type (2015-2020)
6.3 North America Follitropin Market Size by Application (2015-2020)
6.4 North America Follitropin Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Follitropin Market Size (2015-2026)
7.2 Europe Follitropin Market Size by Type (2015-2020)
7.3 Europe Follitropin Market Size by Application (2015-2020)
7.4 Europe Follitropin Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Follitropin Market Size (2015-2026)
8.2 China Follitropin Market Size by Type (2015-2020)
8.3 China Follitropin Market Size by Application (2015-2020)
8.4 China Follitropin Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Follitropin Market Size (2015-2026)
9.2 Japan Follitropin Market Size by Type (2015-2020)
9.3 Japan Follitropin Market Size by Application (2015-2020)
9.4 Japan Follitropin Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Follitropin Market Size (2015-2026)
10.2 Southeast Asia Follitropin Market Size by Type (2015-2020)
10.3 Southeast Asia Follitropin Market Size by Application (2015-2020)
10.4 Southeast Asia Follitropin Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Gedeon Richter
11.1.1 Gedeon Richter Company Details
11.1.2 Gedeon Richter Business Overview
11.1.3 Gedeon Richter Follitropin Introduction
11.1.4 Gedeon Richter Revenue in Follitropin Business (2015-2020))
11.1.5 Gedeon Richter Recent Development
11.2 Organon
11.2.1 Organon Company Details
11.2.2 Organon Business Overview
11.2.3 Organon Follitropin Introduction
11.2.4 Organon Revenue in Follitropin Business (2015-2020)
11.2.5 Organon Recent Development
11.3 Ferring
11.3.1 Ferring Company Details
11.3.2 Ferring Business Overview
11.3.3 Ferring Follitropin Introduction
11.3.4 Ferring Revenue in Follitropin Business (2015-2020)
11.3.5 Ferring Recent Development
11.4 Emd Serono (Merck)
11.4.1 Emd Serono (Merck) Company Details
11.4.2 Emd Serono (Merck) Business Overview
11.4.3 Emd Serono (Merck) Follitropin Introduction
11.4.4 Emd Serono (Merck) Revenue in Follitropin Business (2015-2020)
11.4.5 Emd Serono (Merck) Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Follitropin Introduction
11.5.4 Johnson & Johnson Revenue in Follitropin Business (2015-2020)
11.5.5 Johnson & Johnson Recent Development
11.6 Solvay
11.6.1 Solvay Company Details
11.6.2 Solvay Business Overview
11.6.3 Solvay Follitropin Introduction
11.6.4 Solvay Revenue in Follitropin Business (2015-2020)
11.6.5 Solvay Recent Development
11.7 Controlled Therapeutics
11.7.1 Controlled Therapeutics Company Details
11.7.2 Controlled Therapeutics Business Overview
11.7.3 Controlled Therapeutics Follitropin Introduction
11.7.4 Controlled Therapeutics Revenue in Follitropin Business (2015-2020)
11.7.5 Controlled Therapeutics Recent Development
11.8 Vetter Pharma-Fertigung GmbH&Co. KG
11.8.1 Vetter Pharma-Fertigung GmbH&Co. KG Company Details
11.8.2 Vetter Pharma-Fertigung GmbH&Co. KG Business Overview
11.8.3 Vetter Pharma-Fertigung GmbH&Co. KG Follitropin Introduction
11.8.4 Vetter Pharma-Fertigung GmbH&Co. KG Revenue in Follitropin Business (2015-2020)
11.8.5 Vetter Pharma-Fertigung GmbH&Co. KG Recent Development
11.9 MSD
11.9.1 MSD Company Details
11.9.2 MSD Business Overview
11.9.3 MSD Follitropin Introduction
11.9.4 MSD Revenue in Follitropin Business (2015-2020)
11.9.5 MSD Recent Development
11.10 IBSA
11.10.1 IBSA Company Details
11.10.2 IBSA Business Overview
11.10.3 IBSA Follitropin Introduction
11.10.4 IBSA Revenue in Follitropin Business (2015-2020)
11.10.5 IBSA Recent Development
11.11 Livzon
10.11.1 Livzon Company Details
10.11.2 Livzon Business Overview
10.11.3 Livzon Follitropin Introduction
10.11.4 Livzon Revenue in Follitropin Business (2015-2020)
10.11.5 Livzon Recent Development
11.12 Techwell
10.12.1 Techwell Company Details
10.12.2 Techwell Business Overview
10.12.3 Techwell Follitropin Introduction
10.12.4 Techwell Revenue in Follitropin Business (2015-2020)
10.12.5 Techwell Recent Development
11.13 GenSci
10.13.1 GenSci Company Details
10.13.2 GenSci Business Overview
10.13.3 GenSci Follitropin Introduction
10.13.4 GenSci Revenue in Follitropin Business (2015-2020)
10.13.5 GenSci Recent Development
11.14 Teva
10.14.1 Teva Company Details
10.14.2 Teva Business Overview
10.14.3 Teva Follitropin Introduction
10.14.4 Teva Revenue in Follitropin Business (2015-2020)
10.14.5 Teva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Follitropin Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Urine-Derived Follicle Stimulating Hormone
1.2.3 Follitropin-α
1.2.4 Follitropin-β
1.3 Market by Application
1.3.1 Global Follitropin Market Share by Application: 2020 VS 2026
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Follitropin Market Perspective (2015-2026)
2.2 Global Follitropin Growth Trends by Regions
2.2.1 Follitropin Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Follitropin Historic Market Share by Regions (2015-2020)
2.2.3 Follitropin Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Follitropin Players by Market Size
3.1.1 Global Top Follitropin Players by Revenue (2015-2020)
3.1.2 Global Follitropin Revenue Market Share by Players (2015-2020)
3.2 Global Follitropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Follitropin Revenue
3.4 Global Follitropin Market Concentration Ratio
3.4.1 Global Follitropin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Follitropin Revenue in 2019
3.5 Key Players Follitropin Area Served
3.6 Key Players Follitropin Product Solution and Service
3.7 Date of Enter into Follitropin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Follitropin Breakdown Data by Type (2015-2026)
4.1 Global Follitropin Historic Market Size by Type (2015-2020)
4.2 Global Follitropin Forecasted Market Size by Type (2021-2026)
5 Follitropin Breakdown Data by Application (2015-2026)
5.1 Global Follitropin Historic Market Size by Application (2015-2020)
5.2 Global Follitropin Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Follitropin Market Size (2015-2026)
6.2 North America Follitropin Market Size by Type (2015-2020)
6.3 North America Follitropin Market Size by Application (2015-2020)
6.4 North America Follitropin Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Follitropin Market Size (2015-2026)
7.2 Europe Follitropin Market Size by Type (2015-2020)
7.3 Europe Follitropin Market Size by Application (2015-2020)
7.4 Europe Follitropin Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Follitropin Market Size (2015-2026)
8.2 China Follitropin Market Size by Type (2015-2020)
8.3 China Follitropin Market Size by Application (2015-2020)
8.4 China Follitropin Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Follitropin Market Size (2015-2026)
9.2 Japan Follitropin Market Size by Type (2015-2020)
9.3 Japan Follitropin Market Size by Application (2015-2020)
9.4 Japan Follitropin Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Follitropin Market Size (2015-2026)
10.2 Southeast Asia Follitropin Market Size by Type (2015-2020)
10.3 Southeast Asia Follitropin Market Size by Application (2015-2020)
10.4 Southeast Asia Follitropin Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Gedeon Richter
11.1.1 Gedeon Richter Company Details
11.1.2 Gedeon Richter Business Overview
11.1.3 Gedeon Richter Follitropin Introduction
11.1.4 Gedeon Richter Revenue in Follitropin Business (2015-2020))
11.1.5 Gedeon Richter Recent Development
11.2 Organon
11.2.1 Organon Company Details
11.2.2 Organon Business Overview
11.2.3 Organon Follitropin Introduction
11.2.4 Organon Revenue in Follitropin Business (2015-2020)
11.2.5 Organon Recent Development
11.3 Ferring
11.3.1 Ferring Company Details
11.3.2 Ferring Business Overview
11.3.3 Ferring Follitropin Introduction
11.3.4 Ferring Revenue in Follitropin Business (2015-2020)
11.3.5 Ferring Recent Development
11.4 Emd Serono (Merck)
11.4.1 Emd Serono (Merck) Company Details
11.4.2 Emd Serono (Merck) Business Overview
11.4.3 Emd Serono (Merck) Follitropin Introduction
11.4.4 Emd Serono (Merck) Revenue in Follitropin Business (2015-2020)
11.4.5 Emd Serono (Merck) Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Follitropin Introduction
11.5.4 Johnson & Johnson Revenue in Follitropin Business (2015-2020)
11.5.5 Johnson & Johnson Recent Development
11.6 Solvay
11.6.1 Solvay Company Details
11.6.2 Solvay Business Overview
11.6.3 Solvay Follitropin Introduction
11.6.4 Solvay Revenue in Follitropin Business (2015-2020)
11.6.5 Solvay Recent Development
11.7 Controlled Therapeutics
11.7.1 Controlled Therapeutics Company Details
11.7.2 Controlled Therapeutics Business Overview
11.7.3 Controlled Therapeutics Follitropin Introduction
11.7.4 Controlled Therapeutics Revenue in Follitropin Business (2015-2020)
11.7.5 Controlled Therapeutics Recent Development
11.8 Vetter Pharma-Fertigung GmbH&Co. KG
11.8.1 Vetter Pharma-Fertigung GmbH&Co. KG Company Details
11.8.2 Vetter Pharma-Fertigung GmbH&Co. KG Business Overview
11.8.3 Vetter Pharma-Fertigung GmbH&Co. KG Follitropin Introduction
11.8.4 Vetter Pharma-Fertigung GmbH&Co. KG Revenue in Follitropin Business (2015-2020)
11.8.5 Vetter Pharma-Fertigung GmbH&Co. KG Recent Development
11.9 MSD
11.9.1 MSD Company Details
11.9.2 MSD Business Overview
11.9.3 MSD Follitropin Introduction
11.9.4 MSD Revenue in Follitropin Business (2015-2020)
11.9.5 MSD Recent Development
11.10 IBSA
11.10.1 IBSA Company Details
11.10.2 IBSA Business Overview
11.10.3 IBSA Follitropin Introduction
11.10.4 IBSA Revenue in Follitropin Business (2015-2020)
11.10.5 IBSA Recent Development
11.11 Livzon
10.11.1 Livzon Company Details
10.11.2 Livzon Business Overview
10.11.3 Livzon Follitropin Introduction
10.11.4 Livzon Revenue in Follitropin Business (2015-2020)
10.11.5 Livzon Recent Development
11.12 Techwell
10.12.1 Techwell Company Details
10.12.2 Techwell Business Overview
10.12.3 Techwell Follitropin Introduction
10.12.4 Techwell Revenue in Follitropin Business (2015-2020)
10.12.5 Techwell Recent Development
11.13 GenSci
10.13.1 GenSci Company Details
10.13.2 GenSci Business Overview
10.13.3 GenSci Follitropin Introduction
10.13.4 GenSci Revenue in Follitropin Business (2015-2020)
10.13.5 GenSci Recent Development
11.14 Teva
10.14.1 Teva Company Details
10.14.2 Teva Business Overview
10.14.3 Teva Follitropin Introduction
10.14.4 Teva Revenue in Follitropin Business (2015-2020)
10.14.5 Teva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
